Search in:

Advanced search

Expert Opinion on Drug Safety Volume 14, 2015 - Issue 12

Submit an article Journal homepage

512

Views

CrossRef citations to date

Altmetric

Review

Risks associated with drug treatments for kidney stones

Nadya E. YorkDepartment of Urology, Indiana University School of Medicine, 1801 North Senate Blvd., Suite 220, Indianapolis, IN46202, USA

Michael S. BorofskyDepartment of Urology, Indiana University School of Medicine, 1801 North Senate Blvd., Suite 220, Indianapolis, IN46202, USA

James E. LingemanDepartment of Urology, Indiana University School of Medicine, 1801 North Senate Blvd., Suite 220, Indianapolis, IN46202, USACorrespondence[email protected]

Pages 1865-1877 | Published online: 24 Nov 2015

Cite this article
https://doi.org/10.1517/14740338.2015.1100604
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–96.
PubMedGoogle Scholar
Scales CD, Smith AC, Hanley JM, et al. Project UDiA. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–165.
PubMed Web of Science ®Google Scholar
Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817–1823.
PubMed Web of Science ®Google Scholar
Ngo TC, Assimos DG. Uric Acid nephrolithiasis: recent progress and future directions. Rev Urol. 2007;9(1):17–27.
PubMedGoogle Scholar

*Excellent review of uric acid metabolism and pathophysiology.

Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316–324.
PubMed Web of Science ®Google Scholar

*A must read for any physician involved in management of renal stones. Summary of all key evidence and clear guidelines.

Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984;215(4):383–389.
PubMed Web of Science ®Google Scholar
Arrabal-Martín M, Fernández-Rodríguez A, Arrabal-Polo MA, et al. Extracorporeal renal lithotripsy: evolution of residual lithiasis treated with thiazides. Urology. 2006;68(5):956–959.
PubMed Web of Science ®Google Scholar
Yendt ER, Cohanim M. Prevention of calcium stones with thiazides. Kidney Int. 1978;13(5):397–409.
PubMed Web of Science ®Google Scholar

*An original article from the 1970s describing thiazide effects and common reactions.

Pak CY, Peterson R, Sakhaee K, et al. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med. 1985;79(3):284–288.
PubMed Web of Science ®Google Scholar
Chlorothiazide | Drug Summary | PDR.net. 2015 [cited 2015 Nov 12]. Available from: http://www.pdr.net/drug-summary/chlorothiazide?druglabelid=1960.
Google Scholar
Amiloride Hydrochloride and Hydrochlorothiazide | Drug Summary | PDR.net. 2015 [cited 2015 Nov 12]. Available from: http://www.pdr.net/drug-summary/amiloride-hydrochloride-and-hydrochlorothiazide?druglabelid=1785&id=2883.
Google Scholar
Dyazide | Drug Summary | PDR.net. 2015 [cited 2015 Nov 12]. Available from: http://www.pdr.net/full-prescribing-information/Dyazide-hydrochlorothiazide-triamterene-184.
Google Scholar
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT). JAMA. 2002;288(23):2998–3007.
PubMed Web of Science ®Google Scholar
Arrow-Bendrofluazide | New Zealand Data Sheet | medsafe.govt.nz. 2015 [ cited 2015 Jun 14/]. Available from: http://www.medsafe.govt.nz/profs/datasheet/a/arrow-bendrofluazidetab.pdf.
Google Scholar
Ellison DH, Loffing J. Thiazide effects and adverse effects: insights from molecular genetics. Hypertension. 2009;54(2):196–202.
PubMed Web of Science ®Google Scholar
Hydrochlorothiazide Tablets | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/hydrochlorothiazide-tablets?druglabelid=1973&id=1942.
Google Scholar
Ceylan K, Topal C, Erkoc R, et al. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ann Pharmacother. 2005;39(6):1034–1038.
PubMed Web of Science ®Google Scholar
Borghi L, Meschi T, Guerra A, et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993;22(Suppl 6):S78–86.
PubMed Web of Science ®Google Scholar
Indapamide | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/indapamide?druglabelid=2292.
Google Scholar
Amiloride Hydrochloride | Drug Summary | PDR.net. 2015 [ cited 2015 Jul 12]; Available from: http://www.pdr.net/drug-summary/amiloride-hydrochloride?druglabelid=1840.
Google Scholar
Maschio G, Tessitore N, D’Angelo A, et al. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol. Am J Med. 1981;71(4):623–626.
PubMed Web of Science ®Google Scholar
Goldberg H, Grass L, Vogl R, et al. Urine citrate and renal stone disease. CMAJ. 1989;141(3):217–221.
PubMed Web of Science ®Google Scholar

**Excellent review of citrate metabolism in the urine and its implications.

Pearle MS, Lotan Y. Urinary lithiasis: etiology, epimiology and pathogenesis. In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-Walsh urology. 10th ed. Philadelphia (PA): Elsevier Saunders; 2012. p. 1257–1286.
Google Scholar
Biasz S, Felix R, Newman W, et al. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Miner Electrolyte Metab. 1978;1:74–83.
Google Scholar
Pak CY, Fuller C. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med. 1986;104(1):33–37.
PubMed Web of Science ®Google Scholar
Rudman D, Kutner MH, Redd SC, et al. Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab. 1982;55(6):1052–1057.
PubMed Web of Science ®Google Scholar
Urinary Alkalinization Medication | Drugs.com. 2015 [ cited Jul 30 2015]. Available from: http://www.drugs.com/condition/urinary-alkalinization.html.
Google Scholar
Urocit-K | Drug Summary | PDR.net. 2015 [ cited 2015 Jul 30]. Available from: http://www.pdr.net/drug-summary/urocit-k?druglabelid=414.
Google Scholar
RxMed: Pharmaceutical Information - POLYCITRA. 2015 [ cited 30 Jul 2015]. Available from: http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20(General%20Monographs-%20P)/POLYCITRA.html.
Google Scholar
DailyMed - ORACIT- citric acid monohydrate and trisodium citrate dihydrate liquid. 2015 [ cited July 30 2015]. Available from: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8918fc4-679e-41a9-8d0f-68436aed966b.
Google Scholar
Albrights Solution, Bicitra (sodium citrate/citric acid) dosing, indications, interactions, adverse effects, and more. 2015 [ cited July 30 2015]. Available from: http://reference.medscape.com/drug/albrights-solution-cytra-2-sodium-citrate-citric-acid-342854.
Google Scholar
Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982;22(3):292–296.
PubMed Web of Science ®Google Scholar
Urocit-K | FULL Prescribing Information | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/full-prescribing-information/urocit-k?druglabelid=414.
Google Scholar
Potassium citrate tablets for nephrolithiasis. Med Lett Drugs Ther. 1986;28(712):48.
PubMed Web of Science ®Google Scholar
Ferrandino MN, Pietrow PK, Preminger GM. Evaluation and medical management of urinary lithiasis. In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-Walsh urology. 10th ed. Philadelphia (PA): Elsevier Saunders; 2012. p. 1287–1323.
Google Scholar
Sakhaee K, Poindexter JR, Griffith CS, et al. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004;172(3):958–961.
PubMed Web of Science ®Google Scholar
Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ. 2006;174(10):1407–1409.
PubMed Web of Science ®Google Scholar
Mandel NS, Mandel GS. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol. 1989;142(6):1516–1521.
PubMed Web of Science ®Google Scholar
Coe FL, Strauss AL, Tembe V, et al. Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980;17(5):662–668.
PubMed Web of Science ®Google Scholar
Pak CY, Sakhaee K, Peterson RD, et al. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001;60(2):757–761.
PubMed Web of Science ®Google Scholar
Maalouf NM, Cameron MA, Moe OW, et al. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens. 2004;13(2):181–189.
PubMed Web of Science ®Google Scholar
Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87–114.
PubMed Web of Science ®Google Scholar
Zyloprim | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/zyloprim?druglabelid=816&id=988.
Google Scholar
Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol. 2002;14(3):281–286.
PubMed Web of Science ®Google Scholar
Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984;76(1):47–56.
PubMed Web of Science ®Google Scholar
Terkeltaub RA. Clinical practice. Gout. N Engl J Med. 2003;349(17):1647–1655.
PubMed Web of Science ®Google Scholar
Becker MA, Schumacher HR, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353(23):2450–2461.
PubMed Web of Science ®Google Scholar
Goldfarb DS, MacDonald PA, Gunawardhana L, et al. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones. Clin J Am Soc Nephrol. 2013;8(11):1960–1967.
PubMed Web of Science ®Google Scholar

**First new drug for hyperuricosuria treatment in decades. Important study reviewing its effects.

Uloric | FULL Prescribing Information | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/full-prescribing-information/uloric?druglabelid=563#i4i_section_ID_s6.1.
Google Scholar
Ng CS, Streem SB. Contemporary management of cystinuria. J Endourol. 1999;13(9):647–651.
PubMed Web of Science ®Google Scholar
Joly D, Rieu P, Méjean A, et al. Treatment of cystinuria. Pediatr Nephrol. 1999;13(9):945–950.
PubMed Web of Science ®Google Scholar
Saravakos P, Kokkinou V, Giannatos E. Cystinuria: current diagnosis and management. Urology. 2014;83(4):693–699.
PubMed Web of Science ®Google Scholar
Thiola | FULL Prescribing Information | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/full-prescribing-information/thiola?druglabelid=3227.
Google Scholar
Pak CY, Fuller CJ. Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol. 1983;129(5):1066–1070.
PubMed Web of Science ®Google Scholar
Pak CY, Fuller C, Sakhaee K, et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986;136(5):1003–1008.
PubMed Web of Science ®Google Scholar
Cuprimine | Drug Summary | PDR.net. 2015 [ cited 2015 Nov 12]. Available from: http://www.pdr.net/drug-summary/Cuprimine-penicillamine-1452.
Google Scholar
Andonopoulos AP, Terzis E, Tsibri E, et al. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence? Clin Rheumatol. 1994;13(4):586–588.
PubMed Web of Science ®Google Scholar
Sloand JA, Izzo JL. Captopril reduces urinary cystine excretion in cystinuria. Arch Intern Med. 1987;147(8):1409–1412.
PubMed Web of Science ®Google Scholar
Perazella MA, Buller GK. Successful treatment of cystinuria with captopril. Am J Kidney Dis. 1993;21(5):504–507.
PubMed Web of Science ®Google Scholar
Barbey F, Joly D, Rieu P, et al. Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol. 2000;163(5):1419–1423.
PubMed Web of Science ®Google Scholar
Dahlberg PJ, Jones JD Cystinuria: failure of captopril to reduce cystine excretion. Arch Intern Med. 1989;149(3):713. 17.
PubMedGoogle Scholar
du Toit PJ, van Aswegen CH, Nel JA, et al. In vivo effects of urease-producing bacteria involved with the pathogenesis of infection-induced urolithiasis on renal urokinase and sialidase activity. Urol Res. 1995;23(5):335–338.
PubMed Web of Science ®Google Scholar
Griffith DP, Bruce RR, Fishbein WN. Adapted from: Infection (urease)-induced stones. In: Coe FL, Brenner BM, Stein JH, editors. Nephrolithiasis, contemporary issues in nephrology. New York: Churchill Livingstone; 1980. p. 231–260.
Google Scholar
Griffith DP, Gibson JR, Clinton CW, et al. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J Urol. 1978;119(1):9–15.
PubMed Web of Science ®Google Scholar
Lithostat | FULL Prescribing Information | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/full-prescribing-information/lithostat?druglabelid=3224.
Google Scholar
ACETOHYDROXAMIC ACID - National Library of Medicine HSDB Database. 2015 [ cited 06/1 4/2015]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/.
Google Scholar
Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 2000;31(Suppl 5):S202–210.
PubMed Web of Science ®Google Scholar
Serinken M, Eken C, Turkcuer I, et al. Intravenous paracetamol versus morphine for renal colic in the emergency department: a randomised double-blind controlled trial. Emerg Med J. 2012;29(11):902–905.
PubMed Web of Science ®Google Scholar
Bektas F, Eken C, Karadeniz O, et al. Intravenous paracetamol or morphine for the treatment of renal colic: a randomized, placebo-controlled trial. Ann Emerg Med. 2009;54(4):568–574.
PubMed Web of Science ®Google Scholar
Extra Strength Tylenol Cold Sore Throat Liquid | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/extra-strength-tylenol-cold-sore-throat-liquid?druglabelid=3253&id=1501.
Google Scholar
Paracetamol | Data Sheet | medsafe.govt.nz. 2015 [ cited 2015 Jun 14]. Available from: http://www.medsafe.govt.nz/profs/datasheet/p/panadoltab.pdf.
Google Scholar
Routledge P, Vale JA, Bateman DN, et al. Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments. BMJ. 1998;317(7173):1609–1610.
PubMed Web of Science ®Google Scholar
Botting RM. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses. J Physiol Pharmacol. 2006;57(Suppl 5):113–124.
PubMed Web of Science ®Google Scholar
Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ. 2004;328(7453):1401.
PubMed Web of Science ®Google Scholar
Afshar K, Jafari S, Marks AJ, et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic. Cochrane Database Syst Rev. 2015;6:Cd006027.
PubMed Web of Science ®Google Scholar
Opgenorth TJ, Fiksen-Olsen MJ, Romero JC. Role of prostaglandins in the cortical distribution of renal blood flow following reductions in renal perfusion pressure. Prostaglandins. 1987;34(4):591–602.
PubMed Web of Science ®Google Scholar
Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 1991;31(7):588–598.
PubMed Web of Science ®Google Scholar
Voltaren XR. Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/voltaren-xr?druglabelid=2033&id=756.
Google Scholar
Lanza FL, Chan FK, Quigley EM, Gastroenterology PPCotACo. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728–738.
PubMed Web of Science ®Google Scholar
Becker JC, Domschke W, Pohle T. Current approaches to prevent NSAID-induced gastropathy–COX selectivity and beyond. Br J Clin Pharmacol. 2004;58(6):587–600.
PubMed Web of Science ®Google Scholar
Toepfer NJ, Baylor K, Henry Y, et al. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy. Urology. 2013;82(4):773–779.
PubMed Web of Science ®Google Scholar
Lennon GM, Bourke J, Ryan PC, et al. Pharmacological options for the treatment of acute ureteric colic. An in vitro experimental study. Br J Urol. 1993;71(4):401–407.
PubMedGoogle Scholar
Cordell WH, Wright SW, Wolfson AB, et al. Comparison of intravenous ketorolac, meperidine, and both (balanced analgesia) for renal colic. Ann Emerg Med. 1996;28(2):151–158.
Google Scholar
Ketorolac Tromethamine Tablets | Drug Summary | PDR.net. 2015 [ cited 2015 Nov 12]. Available from: http://www.pdr.net/drug-summary/Ketorolac-Tromethamine-Tablets-ketorolac-tromethamine-1793.3935.
Google Scholar
Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343(21):1520–1528. 2 p following 28.
PubMed Web of Science ®Google Scholar

**Important study pointing out increased cardiovascular risks with COX-2 inhibitors.

Celebrex | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/celebrex?druglabelid=532&id=928.
Google Scholar
Nakada SY, Jerde TJ, Bjorling DE, et al. Selective cyclooxygenase-2 inhibitors reduce uret eral contraction in vitro: a better alternative for renal colic? J Urol. 2000;163(2):607–612.
PubMed Web of Science ®Google Scholar
Bovill JG. Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs. Eur J Anaesthesiol Suppl. 1997;15:9–15.
PubMedGoogle Scholar
Candiotti KA, Gitlin MC. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Curr Med Res Opin. 2010;26(7):1677–1684.
PubMed Web of Science ®Google Scholar
Avinza | Drug Summary | PDR.net. 2015 [ cited 2015 Nov 12]. Available from: http://www.pdr.net/drug-summary/Avinza-morphine-sulfate-2277.781.
Google Scholar
Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943–1953.
PubMed Web of Science ®Google Scholar
Paronis CA, Holtzman SG. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J Pharmacol Exp Ther. 1992;262(1):1–9.
PubMed Web of Science ®Google Scholar
Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9(1):53–68.
PubMedGoogle Scholar
Weiner AL. Meperidine as a potential cause of serotonin syndrome in the emergency department. Acad Emergency Med: Official J Soc Acad Emerg Med. 1999;6(2):156–158.
PubMed Web of Science ®Google Scholar
Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther. 1992;260(1):275–285.
PubMed Web of Science ®Google Scholar
Hazhir S, Badr YA, Darabi JN. Comparison of intranasal desmopressin and intramuscular tramadol versus pethidine in patients with renal colic. Urol J. 2010;7(3):148–151.
PubMed Web of Science ®Google Scholar
Ultram | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/ultram?druglabelid=950&id=904.
Google Scholar
Mahlberg R, Kunz D, Sasse J, et al. Serotonin syndrome with tramadol and citalopram. Am J Psychiatry. 2004;161(6):1129.
PubMed Web of Science ®Google Scholar
Iqbal MM, Basil MJ, Kaplan J, et al. Overview of serotonin syndrome. Ann Clin Psychiatry. 2012;24(4):310–318.
PubMed Web of Science ®Google Scholar
Miyaoka R, Monga M. Ureteral stent discomfort: etiology and management. Indian J Urol. 2009;25(4):455–460.
PubMedGoogle Scholar
Pyridium | Drug Summary | PDR.net. 2015 [ cited 2015 Nov 12]. Available from: http://www.pdr.net/drug-summary/Pyridium-phenazopyridine-hydrochloride-3457.
Google Scholar
Malin JM, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol. 1970;42(2):171–174.
PubMedGoogle Scholar
Lipkin M, Shah O. The use of alpha-blockers for the treatment of nephrolithiasis. Rev Urol. 2006;8(Suppl 4):S35–42.
PubMedGoogle Scholar

**Excellent, clear review of the subject.

Lamb AD, Vowler SL, Johnston R, et al. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort. BJU Int. 2011;108(11):1894–1902.
PubMed Web of Science ®Google Scholar
Lepor H. Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol. 2007;9(4):181–190.
PubMedGoogle Scholar
Richardson CD, Donatucci CF, Page SO, et al. Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. Prostate. 1997;33(1):55–59.
PubMed Web of Science ®Google Scholar
Sigala S, Dellabella M, Milanese G, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn. 2005;24(2): 142–148.
PubMed Web of Science ®Google Scholar
De Sio M, Autorino R, Di Lorenzo G, et al. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol. 2006;20(1):12–16.
PubMed Web of Science ®Google Scholar
Pickard R, Starr K, MacLennan G, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet. 2015;386(9991):341–349.
PubMed Web of Science ®Google Scholar

**Fresh-off-the-press new trial demonstrating ineffectiveness of MET.

Hellstrom WJ, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol. 2006;176(4 Pt 1):1529–1533.
PubMed Web of Science ®Google Scholar
Committee APG. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003;170(2 Pt 1):530–547.
PubMed Web of Science ®Google Scholar
Nazim SM, Ather MH. Alpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trial. J Endourol. 2012;26(9):1237–1241.
PubMed Web of Science ®Google Scholar
Seitz C, Liatsikos E, Porpiglia F, et al. Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol. 2009;56(3):455–471.
PubMed Web of Science ®Google Scholar

**Meta-analysis of MET with clear presentation of results.

Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol. 2005;174(1):167–172.
PubMed Web of Science ®Google Scholar
Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology. 2005;66(4):712–715.
PubMed Web of Science ®Google Scholar
Mukamel E, Engelstein D, Simon D, et al. The value of Rowatinex in the treatment of ureterolithiasis. J Urol (Paris). 1987;93(1):31–33.
PubMedGoogle Scholar
Romics I, Siller G, Kohnen R, et al. A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial. Urol Int. 2011;86(1):102–109.
PubMed Web of Science ®Google Scholar
Djaladat H, Mahouri K, Khalifeh Shooshtary F, et al. Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy. Urol J. 2009;6(1):9–13.
PubMed Web of Science ®Google Scholar
Aldemir M, Uçgül YE, Kayıgil O. Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study. Int Urol Nephrol. 2011;43(1):79–83.
PubMed Web of Science ®Google Scholar
Troxel SA, Jones AW, Magliola L, et al. Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol. 2006;20(8):565–568.
PubMed Web of Science ®Google Scholar
Nifedipine | Drug Summary | PDR.net. 2015 [ cited 2015 Jun 14]. Available from: http://www.pdr.net/drug-summary/nifedipine?druglabelid=1481&id=932
Google Scholar
ALLN-177 drug information. 2015 [ cited 2015 Jun 14]. Available from: http://www.allenapharma.com/therapeutic-approach-ALLN.php.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Risks associated with drug treatments for kidney stones

Bibliography

*Excellent review of uric acid metabolism and pathophysiology.

*A must read for any physician involved in management of renal stones. Summary of all key evidence and clear guidelines.

*An original article from the 1970s describing thiazide effects and common reactions.

**Excellent review of citrate metabolism in the urine and its implications.

**First new drug for hyperuricosuria treatment in decades. Important study reviewing its effects.

**Important study pointing out increased cardiovascular risks with COX-2 inhibitors.

**Excellent, clear review of the subject.

**Fresh-off-the-press new trial demonstrating ineffectiveness of MET.

**Meta-analysis of MET with clear presentation of results.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Risks associated with drug treatments for kidney stones

Bibliography

*Excellent review of uric acid metabolism and pathophysiology.

*A must read for any physician involved in management of renal stones. Summary of all key evidence and clear guidelines.

*An original article from the 1970s describing thiazide effects and common reactions.

**Excellent review of citrate metabolism in the urine and its implications.

**First new drug for hyperuricosuria treatment in decades. Important study reviewing its effects.

**Important study pointing out increased cardiovascular risks with COX-2 inhibitors.

**Excellent, clear review of the subject.

**Fresh-off-the-press new trial demonstrating ineffectiveness of MET.

**Meta-analysis of MET with clear presentation of results.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date